OBJECTIVES: In a matched analysis, we investigated clinical, histopathological, and survival characteristics of small (<or=2 cm) pancreatic cancer (PaC) as compared to large PaC. METHODS: From the Mayo pathology database, we identified 41 consecutive patients with small PaC and 94 matched controls with margin-negative PaC >2 cm. Two experienced pathologists, who were blinded to survival data, independently reviewed tumor stage and differentiation. Kaplan-Meier survival analysis and Cox proportional hazards models were applied for data analyses. RESULTS: In patients with localized disease (stages I and II), survival was similar in small and large PaC but survival was significantly better in small PaC with regional nodal metastasis (stage III) as compared to similar stage large PaC (5-year survival 44 vs. 7%, median survival 58 vs.18 months, p < 0.001). Well-differentiated small and large PaC had similar median survival (76 vs. 74 months, p = NS). In multivariate analysis, tumor differentiation, not tumor size, was the only independent factor predicting survival in PaC (risk ratio, RR, for moderate vs. well- differentiated: 2.6, 95% confidence interval, CI, 1.5-4.5, and RR for poorly differentiated vs. well-differentiated: 5.0, 95% CI 2.4-10.1). CONCLUSION: Tumor differentiation may be a better predictor of survival in resectable PaC than tumor stage. Copyright 2008 S. Karger AG, Basel and IAP.
OBJECTIVES: In a matched analysis, we investigated clinical, histopathological, and survival characteristics of small (<or=2 cm) pancreatic cancer (PaC) as compared to large PaC. METHODS: From the Mayo pathology database, we identified 41 consecutive patients with small PaC and 94 matched controls with margin-negative PaC >2 cm. Two experienced pathologists, who were blinded to survival data, independently reviewed tumor stage and differentiation. Kaplan-Meier survival analysis and Cox proportional hazards models were applied for data analyses. RESULTS: In patients with localized disease (stages I and II), survival was similar in small and large PaC but survival was significantly better in small PaC with regional nodal metastasis (stage III) as compared to similar stage large PaC (5-year survival 44 vs. 7%, median survival 58 vs.18 months, p < 0.001). Well-differentiated small and large PaC had similar median survival (76 vs. 74 months, p = NS). In multivariate analysis, tumor differentiation, not tumor size, was the only independent factor predicting survival in PaC (risk ratio, RR, for moderate vs. well- differentiated: 2.6, 95% confidence interval, CI, 1.5-4.5, and RR for poorly differentiated vs. well-differentiated: 5.0, 95% CI 2.4-10.1). CONCLUSION:Tumor differentiation may be a better predictor of survival in resectable PaC than tumor stage. Copyright 2008 S. Karger AG, Basel and IAP.
Authors: N A Ahmad; J D Lewis; G G Ginsberg; D G Haller; J B Morris; N N Williams; E F Rosato; M L Kochman Journal: Am J Gastroenterol Date: 2001-09 Impact factor: 10.864
Authors: R C van Geenen; T M van Gulik; G J Offerhaus; L T de Wit; O R Busch; H Obertop; D J Gouma Journal: Eur J Surg Oncol Date: 2001-09 Impact factor: 4.424
Authors: R Tsuchiya; T Noda; N Harada; T Miyamoto; T Tomioka; K Yamamoto; T Yamaguchi; K Izawa; T Tsunoda; R Yoshino Journal: Ann Surg Date: 1986-01 Impact factor: 12.969
Authors: T Tsunoda; Y Yamamoto; M Kimoto; H Imai; S Iwamoto; S Kawasaki; K Kawashima; Y Tadaoka; T Majima; E Onuma; K Iki; T Kubozoe; T Eto Journal: J Hepatobiliary Pancreat Surg Date: 1998
Authors: Amanda Blackford; Oscar K Serrano; Christopher L Wolfgang; Giovanni Parmigiani; Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; James R Eshleman; Michael Goggins; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; John L Cameron; Kelly Olino; Richard Schulick; Jordan Winter; Joseph M Herman; Daniel Laheru; Alison P Klein; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Ralph H Hruban Journal: Clin Cancer Res Date: 2009-07-07 Impact factor: 12.531
Authors: Barbara Kenner; Suresh T Chari; David Kelsen; David S Klimstra; Stephen J Pandol; Michael Rosenthal; Anil K Rustgi; James A Taylor; Adam Yala; Noura Abul-Husn; Dana K Andersen; David Bernstein; Søren Brunak; Marcia Irene Canto; Yonina C Eldar; Elliot K Fishman; Julie Fleshman; Vay Liang W Go; Jane M Holt; Bruce Field; Ann Goldberg; William Hoos; Christine Iacobuzio-Donahue; Debiao Li; Graham Lidgard; Anirban Maitra; Lynn M Matrisian; Sung Poblete; Laura Rothschild; Chris Sander; Lawrence H Schwartz; Uri Shalit; Sudhir Srivastava; Brian Wolpin Journal: Pancreas Date: 2021-03-01 Impact factor: 3.243
Authors: Hong Peng; Sheng Pan; Yuanqing Yan; Randall E Brand; Gloria M Petersen; Suresh T Chari; Lisa A Lai; Jimmy K Eng; Teresa A Brentnall; Ru Chen Journal: Cancers (Basel) Date: 2020-06-11 Impact factor: 6.575